• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PeerJ . An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2

tetano

Editor, Senior Moderator
PeerJ


. 2022 Mar 21;10:e13136.
doi: 10.7717/peerj.13136. eCollection 2022.
An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2


Sk Sarif Hassan[SUP] 1 [/SUP], Vaishnavi Kodakandla[SUP] 2 [/SUP], Elrashdy M Redwan[SUP] 3 [/SUP], Kenneth Lundstrom[SUP] 4 [/SUP], Pabitra Pal Choudhury[SUP] 5 [/SUP], Tarek Mohamed Abd El-Aziz[SUP] 6 [/SUP], Kazuo Takayama[SUP] 7 [/SUP], Ramesh Kandimalla[SUP] 8 [/SUP], Amos Lal[SUP] 9 [/SUP], Ángel Serrano-Aroca[SUP] 10 [/SUP], Gajendra Kumar Azad[SUP] 11 [/SUP], Alaa A A Aljabali[SUP] 12 [/SUP], Giorgio Palù[SUP] 13 [/SUP], Gaurav Chauhan[SUP] 14 [/SUP], Parise Adadi[SUP] 15 [/SUP], Murtaza Tambuwala[SUP] 16 [/SUP], Adam M Brufsky[SUP] 17 [/SUP], Wagner Baetas-da-Cruz[SUP] 18 [/SUP], Debmalya Barh[SUP] 19 [/SUP], Vasco Azevedo[SUP] 20 [/SUP], Nikolas G Bazan[SUP] 21 [/SUP], Bruno Silva Andrade[SUP] 22 [/SUP], Raner José Santana Silva[SUP] 23 [/SUP], Vladimir N Uversky[SUP] 24 [/SUP]



Affiliations

Abstract

Open reading frame 8 (ORF8) shows one of the highest levels of variability among accessory proteins in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19). It was previously reported that the ORF8 protein inhibits the presentation of viral antigens by the major histocompatibility complex class I (MHC-I), which interacts with host factors involved in pulmonary inflammation. The ORF8 protein assists SARS-CoV-2 in evading immunity and plays a role in SARS-CoV-2 replication. Among many contributing mutations, Q27STOP, a mutation in the ORF8 protein, defines the B.1.1.7 lineage of SARS-CoV-2, engendering the second wave of COVID-19. In the present study, 47 unique truncated ORF8 proteins (T-ORF8) with the Q27STOP mutations were identified among 49,055 available B.1.1.7 SARS-CoV-2 sequences. The results show that only one of the 47 T-ORF8 variants spread to over 57 geo-locations in North America, and other continents, which include Africa, Asia, Europe and South America. Based on various quantitative features, such as amino acid homology, polar/non-polar sequence homology, Shannon entropy conservation, and other physicochemical properties of all specific 47 T-ORF8 protein variants, nine possible T-ORF8 unique variants were defined. The question as to whether T-ORF8 variants function similarly to the wild type ORF8 is yet to be investigated. A positive response to the question could exacerbate future COVID-19 waves, necessitating severe containment measures.

Keywords: COVID-19; Continent distribution; Intrinsically disordered region; ORF8; SARS-CoV-2; Truncated; Truncation mutation.
 
Back
Top Bottom